Your browser doesn't support javascript.
loading
Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry.
Hidekawa, Chiharu; Yoshimi, Ryusuke; Saigusa, Yusuke; Tamura, Jun; Kojitani, Noriko; Suzuki, Naoki; Sakurai, Natsuki; Yoshioka, Yuji; Sugiyama-Kawahara, Yumiko; Kunishita, Yosuke; Kishimoto, Daiga; Higashitani, Kana; Sato, Yuichiro; Komiya, Takaaki; Nagai, Hideto; Hamada, Naoki; Maeda, Ayaka; Tsuchida, Naomi; Hirahara, Lisa; Soejima, Yutaro; Takase-Minegishi, Kaoru; Kirino, Yohei; Yajima, Nobuyuki; Sada, Ken-Ei; Miyawaki, Yoshia; Ichinose, Kunihiro; Ohno, Shigeru; Kajiyama, Hiroshi; Sato, Shuzo; Shimojima, Yasuhiro; Fujiwara, Michio; Nakajima, Hideaki.
Affiliation
  • Hidekawa C; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Saigusa Y; Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan.
  • Tamura J; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
  • Kojitani N; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
  • Suzuki N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Sakurai N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yoshioka Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Sugiyama-Kawahara Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kishimoto D; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Higashitani K; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan.
  • Sato Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Komiya T; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Nagai H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hamada N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Maeda A; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Tsuchida N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hirahara L; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Soejima Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yajima N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Sada KE; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Miyawaki Y; Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku, Japan.
  • Ichinose K; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Ohno S; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kajiyama H; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan.
  • Sato S; Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Morohongo, Japan.
  • Shimojima Y; Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Fujiwara M; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
  • Nakajima H; Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan.
Front Immunol ; 14: 1227403, 2023.
Article in En | MEDLINE | ID: mdl-37720209
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxychloroquine / Lupus Erythematosus, Systemic Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxychloroquine / Lupus Erythematosus, Systemic Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Japan